praventin clinical trials

69
References 1. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci 25:77-83. Chiba, K., K. Yoshizawa, I. Makino, K. Kawakami, and M. Onoue. 2000. 2. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 16:417-9. Brock, J. 1995. 3. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 132:352-9. Cumberbatch, M., M. Bhushan, R. J. Dearman, I. Kimber, and C. E. Griffiths. 2003. 4. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 80:103-7. Kimber, I., M. Cumberbatch, R. J. Dearman, D. R. Headon, M. Bhushan, and C. E. Griffiths. 2002. 5. Lactoferrin--a multifunctional protein with antimicrobial properties. Mol Immunol 40:395-405. Farnaud, S., and R. W. Evans. 2003. 6. Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 17:231-4. Teraguchi, S., H. Wakabayashi, H. Kuwata, K. Yamauchi, and Y. Tamura. 2004. 7. Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals 17:203-8. Ward, P. P., and O. M. Conneely. 2004. 8. Acne – Inflammatory Affection of Pilo Sebaceaous Follicle: The Most Frequent reason for consulting a dermatologist A report by Professor Brigitte Dremo and Dr Amir Khammari. Business Briefing European Pharmacotherapy 2003. 9. The Response of Skin Disease to Stress: changes in the severity of acne vulgaris as affected by examination stress Chiu A, Chon SY, Kimball AB. Arch Dermatol. 2003 Jul;139(7):897-900. 10. Eight week Data Analysis Report for Bioactive Protein & Teenage Acne Test Market & Consumer Research Study prepared for DMV International by Jeffrey D Dawson 2005 11. Three Group Data Analysis Report of Eight Week Praventin™ Study Prepared for DMV International by Jeffrey D Dawson 2006 PAGE 2 9 12 20 25 36 40 46 51 55 64

Upload: symonjosef-concha

Post on 12-Apr-2015

50 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Praventin Clinical Trials

References

1. Comedogenicity of squalene monohydroperoxide in the skin after topical application.

J Toxicol Sci 25:77-83. Chiba, K., K. Yoshizawa, I. Makino, K. Kawakami, and M. Onoue. 2000.

2. Lactoferrin: a multifunctional immunoregulatory protein?

Immunol Today 16:417-9. Brock, J. 1995.

3. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation

by lactoferrin.

Clin Exp Immunol 132:352-9. Cumberbatch, M., M. Bhushan, R. J. Dearman, I. Kimber, and C. E.

Griffiths. 2003.

4. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation.

Biochem Cell Biol 80:103-7. Kimber, I., M. Cumberbatch, R. J. Dearman, D. R. Headon, M. Bhushan, and

C. E. Griffiths. 2002.

5. Lactoferrin--a multifunctional protein with antimicrobial properties.

Mol Immunol 40:395-405. Farnaud, S., and R. W. Evans. 2003.

6. Protection against infections by oral lactoferrin: evaluation in animal models.

Biometals 17:231-4. Teraguchi, S., H. Wakabayashi, H. Kuwata, K. Yamauchi, and Y. Tamura. 2004.

7. Lactoferrin: role in iron homeostasis and host defense against microbial infection.

Biometals 17:203-8. Ward, P. P., and O. M. Conneely. 2004.

8. Acne – Inflammatory Affection of Pilo Sebaceaous Follicle: The Most Frequent reason for

consulting a dermatologist

A report by Professor Brigitte Dremo and Dr Amir Khammari. Business Briefing European

Pharmacotherapy 2003.

9. The Response of Skin Disease to Stress: changes in the severity of acne vulgaris as affected by

examination stress

Chiu A, Chon SY, Kimball AB. Arch Dermatol. 2003 Jul;139(7):897-900.

10. Eight week Data Analysis Report for Bioactive Protein & Teenage Acne

Test Market & Consumer Research Study prepared for DMV International by Jeffrey D Dawson 2005

11. Three Group Data Analysis Report of Eight Week Praventin™ Study

Prepared for DMV International by Jeffrey D Dawson 2006

PAGE

2

9

12

20

25

36

40

46

51

55

64

Page 2: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 3: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 4: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 5: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 6: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 7: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 8: Praventin Clinical Trials

The Japanese Society of Toxicology

NII-Electronic Library Service

Page 9: Praventin Clinical Trials
Page 10: Praventin Clinical Trials
Page 11: Praventin Clinical Trials
Page 12: Praventin Clinical Trials
Page 13: Praventin Clinical Trials
Page 14: Praventin Clinical Trials
Page 15: Praventin Clinical Trials
Page 16: Praventin Clinical Trials
Page 17: Praventin Clinical Trials
Page 18: Praventin Clinical Trials
Page 19: Praventin Clinical Trials
Page 20: Praventin Clinical Trials
Page 21: Praventin Clinical Trials
Page 22: Praventin Clinical Trials
Page 23: Praventin Clinical Trials
Page 24: Praventin Clinical Trials
Page 25: Praventin Clinical Trials
Page 26: Praventin Clinical Trials
Page 27: Praventin Clinical Trials
Page 28: Praventin Clinical Trials
Page 29: Praventin Clinical Trials
Page 30: Praventin Clinical Trials
Page 31: Praventin Clinical Trials
Page 32: Praventin Clinical Trials
Page 33: Praventin Clinical Trials
Page 34: Praventin Clinical Trials
Page 35: Praventin Clinical Trials
Page 36: Praventin Clinical Trials
Page 37: Praventin Clinical Trials
Page 38: Praventin Clinical Trials
Page 39: Praventin Clinical Trials
Page 40: Praventin Clinical Trials
Page 41: Praventin Clinical Trials
Page 42: Praventin Clinical Trials
Page 43: Praventin Clinical Trials
Page 44: Praventin Clinical Trials
Page 45: Praventin Clinical Trials
Page 46: Praventin Clinical Trials
Page 47: Praventin Clinical Trials
Page 48: Praventin Clinical Trials
Page 49: Praventin Clinical Trials
Page 50: Praventin Clinical Trials
Page 51: Praventin Clinical Trials
Page 52: Praventin Clinical Trials
Page 53: Praventin Clinical Trials
Page 54: Praventin Clinical Trials
Page 55: Praventin Clinical Trials
Page 56: Praventin Clinical Trials
Page 57: Praventin Clinical Trials
Page 58: Praventin Clinical Trials
Page 59: Praventin Clinical Trials
Page 60: Praventin Clinical Trials
Page 61: Praventin Clinical Trials
Page 62: Praventin Clinical Trials
Page 63: Praventin Clinical Trials
Page 64: Praventin Clinical Trials
Page 65: Praventin Clinical Trials
Page 66: Praventin Clinical Trials
Page 67: Praventin Clinical Trials
Page 68: Praventin Clinical Trials
Page 69: Praventin Clinical Trials